UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Safety of a GFD in Pregnant Women Without Celiac Disease: Investigating Ingrained Habits

Digestive diseases and sciences, 2020-10, Vol.65 (10), p.2751-2753

2020

Volltextzugriff (PDF)

Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum

Digestive diseases and sciences, 2021-10, Vol.66 (10), p.3303-3306

2021

Volltextzugriff (PDF)

Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy

iMeta, 2024-06, Vol.3 (3), p.e200-n/a

2024

Volltextzugriff (PDF)

Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e1467-e1475

2023

Volltextzugriff (PDF)

EUS imaging for the diagnosis of nonalcoholic fatty liver disease

Gastrointestinal endoscopy, 2022-04, Vol.95 (4), p.711-716

2022

Volltextzugriff (PDF)

Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection

Expert review of gastroenterology & hepatology, 2017-07, Vol.11 (7), p.611-622

2017

Volltextzugriff (PDF)

Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage

Gastroenterology (New York, N.Y. 1943), 2021-06, Vol.160 (7), p.2328-2339.e6

2021

Volltextzugriff (PDF)

An Anti-inflammatory Approach to Drug Repurposing for Clostridioides difficile Infection

The Journal of infectious diseases, 2024-01

2024

Volltextzugriff (PDF)

Patients With Celiac Disease Have a Lower Prevalence of Non–Insulin-Dependent Diabetes Mellitus and Metabolic Syndrome

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.912-917.e1

2013

Volltextzugriff (PDF)

Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis

Nature microbiology, 2019-02, Vol.4 (2), p.269

2019

Volltextzugriff (PDF)

Editorial: Peering through the fog—New tools to assess neurocognitive symptoms in coeliac disease

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (12), p.1628-1629

2024

Volltextzugriff (PDF)

Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed

Clinical infectious diseases, 2021-06, Vol.72 (12), p.e1090-e1092

Villafuerte-Gálvez, Javier A

2021

Volltextzugriff (PDF)

Dating While Gluten-Free—Don’t Kiss and Don’t Tell?

Digestive diseases and sciences, 2022-11, Vol.67 (11), p.4976-4978

2022

Volltextzugriff (PDF)

Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort

Microbiology spectrum, 2022-08, Vol.10 (4), p.e0136222-e0136222

2022

Volltextzugriff (PDF)

Anemia Etiology and the Response to a Gluten-Free Diet in Untreated Patients With Celiac Disease: A 2-Year Follow-Up

The American journal of gastroenterology, 2022-10, Vol.117 (10), p.1684-1692

2022

Volltextzugriff (PDF)

Predictors for Positive Findings on EGD, Colonoscopy, and Biopsy in Non-Responsive Celiac Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S159-S159

2017

Volltextzugriff (PDF)

Prevalence, Causes and Characteristics of Nonresponsive Celiac Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S480-S481

2017

Volltextzugriff (PDF)

Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?

Current opinion in gastroenterology, 2018-01, Vol.34 (1), p.11-18

2018

Volltextzugriff (PDF)

Sa1292 Elevated Serum IL-27 Concentrations Predict Adverse Outcomes in Clostridium difficile Associated Diarrhea

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-253-S-254

2014

Volltextzugriff (PDF)

Sa1291 Evaluation of Adherence to Treatment Guidelines and Outcomes of Clostridium difficile Infection At a Large Teaching Institution

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-253-S-253

2014

Volltextzugriff (PDF)

Sa1293 Serum Cytokine Profiles in Patients With C. difficile Associated-Diarrhea and Non- C. difficile Antibiotic Associated Diarrhea

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-254-S-254

2014

Volltextzugriff (PDF)

Sa1281 Long Term Adherence to a Gluten Free Diet

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-250-S-251

2013

Volltextzugriff (PDF)

Sa1258 Risk of Cardiovascular Disease in Individuals With Celiac Disease

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-244-S-245

2013

Volltextzugriff (PDF)

Sa1271 A Clinical Predictive Model for Differentiation of Celiac Disease and Non-Celiac Gluten Sensitivity

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-248-S-248

2013

Volltextzugriff (PDF)

Mo1114 The Liver in Celiac Disease and Effect of the Gluten Free Diet

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-560-S-560

2014

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(69)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of a GFD in Pregnant Women Without Celiac Disease: Investigating Ingrained Habits

Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum

Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy

Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea

EUS imaging for the diagnosis of nonalcoholic fatty liver disease

Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection

Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage

An Anti-inflammatory Approach to Drug Repurposing for Clostridioides difficile Infection

Patients With Celiac Disease Have a Lower Prevalence of Non–Insulin-Dependent Diabetes Mellitus and Metabolic Syndrome

Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis

Editorial: Peering through the fog—New tools to assess neurocognitive symptoms in coeliac disease

Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed

Dating While Gluten-Free—Don’t Kiss and Don’t Tell?

Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort

Anemia Etiology and the Response to a Gluten-Free Diet in Untreated Patients With Celiac Disease: A 2-Year Follow-Up

Predictors for Positive Findings on EGD, Colonoscopy, and Biopsy in Non-Responsive Celiac Disease

Prevalence, Causes and Characteristics of Nonresponsive Celiac Disease

Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?

Sa1292 Elevated Serum IL-27 Concentrations Predict Adverse Outcomes in Clostridium difficile Associated Diarrhea

Sa1291 Evaluation of Adherence to Treatment Guidelines and Outcomes of Clostridium difficile Infection At a Large Teaching Institution

Sa1293 Serum Cytokine Profiles in Patients With C. difficile Associated-Diarrhea and Non- C. difficile Antibiotic Associated Diarrhea

Sa1281 Long Term Adherence to a Gluten Free Diet

Sa1258 Risk of Cardiovascular Disease in Individuals With Celiac Disease

Sa1271 A Clinical Predictive Model for Differentiation of Celiac Disease and Non-Celiac Gluten Sensitivity

Mo1114 The Liver in Celiac Disease and Effect of the Gluten Free Diet

Suchergebnisse filtern